(1)
Evaluation of CD4+, CD39+, FOXP3+Tregulatory Cells in Iraqi Alopecia Areata Patients by ELISA. Journal of Pharmaceutical Negative Results 2022, 13, 247-250. https://doi.org/10.47750/pnr.2022.13.S05.32.